-
Abstract Number: 2461
Prevalence and Impact of Peripheral Neuropathy in SSc: A Frequent and Disabling Manifestation in SSc, and a Potential Surrogate Marker for Autonomic Neuropathy
-
Abstract Number: 2462
A Potent Inhibitor of PAI-1, MDI-2517, Mitigates Disease Severity in Preclinical Models of Systemic Sclerosis
-
Abstract Number: 2463
Interstitial Lung Disease in Very Early Systemic Sclerosis – a Clinical and Radiological Characterization
-
Abstract Number: 2464
Thymic Size Longitudinal Changes on Chest High-resolution Computed Tomography After Autologous Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis
-
Abstract Number: 2465
Subclinical Loss of Lung Volumes in Very Early SSc: Evidence from Two Independent Cohorts in EUSTAR
-
Abstract Number: 2466
Ranked Composite Important Difference (RCID) Scores in Patients with Diffuse Cutaneous Systemic Sclerosis and Interstitial Lung Disease
-
Abstract Number: 2467
Elderly Systemic Sclerosis. Clinical Presentation and Outcome
-
Abstract Number: 2468
Audio-Guided Imagery Positively Impacted Patients with Raynaud’s Phenomenon Associated Connective Tissue Disease
-
Abstract Number: 2469
Machine Learning Identifies Oesophageal Symptoms as a New Red Flag for for Very Early Diagnosis of Systemic Sclerosis (VEDOSS): A EUSTAR Analysis
-
Abstract Number: 2470
Progression Patterns in Systemic Sclerosis – Associated Interstitial Lung Diseases
-
Abstract Number: 2471
Association of Telangiectasias with Autoantibodies and Clinical Manifestations in Systemic Sclerosis
-
Abstract Number: 2472
Are Anti-centromere Antibodies (aCENP) Predictive of Systemic Sclerosis Development in Patients Without Raynaud´s Phenomenon?
-
Abstract Number: 2473
Criterion Validity of Modified Rodnan Skin Score: Does It Capture Skin Thickness or Hardening? Results of a Large Skin Histology Study
-
Abstract Number: 2474
High-throughput Screening Identifies Specific Molecular Markers for ILD in Patients with Rheumatic Diseases
-
Abstract Number: 2475
The Critical Role of Annual HRCT in Identifying ILD Progression and Assessing Outcome in SSc
- « Previous Page
- 1
- …
- 164
- 165
- 166
- 167
- 168
- …
- 181
- Next Page »